KILIÇ, A. Et Al. 2019. Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , vol.97, no.12 , 1124-1131.

KILIÇ, A., ÜSTÜNOVA, S., Usta, C., Bulut, H., MERAL, İ., Tansel, C., ... Gurevin, E.(2019). Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , vol.97, no.12, 1124-1131.

KILIÇ, Aysu Et Al. "Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart," CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , vol.97, no.12, 1124-1131, 2019

KILIÇ, Aysu Et Al. "Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart." CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , vol.97, no.12, pp.1124-1131, 2019

KILIÇ, A. Et Al. (2019) . "Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart." CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , vol.97, no.12, pp.1124-1131.

@article{article, author={Aysu KILIÇ Et Al. }, title={Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart}, journal={CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY}, year=2019, pages={1124-1131} }